Drug compounding is the practice of mixing or preparing a medication from raw ingredients to fit a specific patient's needs
At follow-up, a self-assessment of change question (SCQ) was administered per domain.Responsiveness was assessed using two construct-based approaches (efficacy-approach and known-groups-approach
Expect: History & exam: weight, waist, BP, heart rate, medication/supplement list, past GI issues, pancreatitis/gallbladder history
Approved medicines have prescribing labels, pharmacy supply chains, adverse-event reporting systems, and post-marketing safety information
Judicial Panel on Multidistrict Litigation approved MDL No
Additionally, with equivocal findings in DR and NAION, discussing personalized ocular risk of starting GLP-1RA in patients is key, and considering increased follow-up frequency after medication initiation may be warranted